Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06568640 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Superselective Adrenal Arterial Embolization for Refractory Hypertension: A Proof-of-Concept Study

Study acronym: SAAE-RH
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The subjects of this study were patients with essential refractory hypertension. The purpose of this study is to evaluate the safety and efficacy of superselective adrenal arterial embolization (SAAE) in patients with primary refractory hypertension and to explore the possibility of SAAE in patients with primary refractory hypertension.After the subject completes the SAAE, an 8-week follow-up will be conducted to assess the safety and effectiveness of the SAAE.
Trial Details
NCT Number NCT06568640
Lead Sponsor Second Affiliated Hospital of Nanchang University
Conditions
(from sponsor)		 Essential Hypertension
Related terms Essential Hypertension
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov